Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Corporation"), a global leader in SaaS clinical division support solutions, is ...
The triplet therapy of ciforadenant, nivolumab (Opdivo), and ipilimumab (Yervoy) showed acceptable safety but failed to improve efficacy in patients with untreated, advanced clear cell kidney cancer ...
(Head of Commercial: Mike Petroutsas, "Astellas") today announced final overall survival (OS) results from the Phase 3 EMBARK study evaluating XTANDI ® (enzalutamide), in combination with leuprolide ...
Combining osimertinib with LCT significantly improved PFS in metastatic EGFR-mutant NSCLC, reducing disease progression risk by 34%. The trial showed enhanced PFS across different EGFR mutation ...
I am a healthy 69-year-old female. I walk every day and belong to an exercise group that I attend twice a week. I’m writing ...
Cumberland to expand its gastroenterology offerings with the market-leading Helicobacter pylori therapy NASHVILLE, Tenn., Oct. 20, 2025 /PRNewswire/ ...
Cumberland to expand its gastroenterology offerings with the market-leading Helicobacter pylori therapy NASHVILLE, Tenn., Oct. 20, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc.
Everyday Health on MSN
Electrolyte Imbalance in Diabetic Ketoacidosis
If you have diabetes, it's important to be familiar with diabetic ketoacidosis (DKA). DKA is a serious complication of ...
Background Despite concerns that non-steroidal anti-inflammatory drugs (NSAIDs) contribute to acute kidney injury (AKI), up to 75% of ultramarathon runners ingest these during competition. The effect ...
I am not a believer of the old eight glasses of water a day theory. I don’t drink soda or energy drinks. I drink coffee, ...
The convicted medical fraudster Walter Magaya has posted new pictures of him “doing 31 days dry fasting” while alone (a period due to end on 5 Nov 2025), sitting on a mountain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback